Samsung Thermo Fisher Scientific Highlights Clinical, Dx Efforts as Part of Overall Growth Strategy Premium During the company's third quarter earnings call, CEO Mark Casper highlighted a number of recent clinical and diagnostic product launches and initiatives. IP Roundup: NYU, Luminex, Quanterix, Samsung, Applied Precision, Fluidigm Win US Patents Premium New York University has been awarded IP Roundup: Meso Scale Technologies, Fluidigm, Affymetrix, Luminex, Honeywell, Samsung Electronics Premium Title: Assay plates, reader systems and methods for luminescence test measurements. Patent Number: 8,808,627 Filed: Nov. 11, 2010 IP Watch: Siemens, Hologic, Samsung, Illumina, Others Win US Patents Premium Siemens has been awarded IP Watch: Diagnoplex, BioMérieux, Fluidigm, Quest, Others Win US Patents Premium The Regents of the University of California have been awarded Mar 4, 2014 IP Watch: Samsung, Agilent, Thermo Fisher, BioMérieux, Bio-Rad, Others Win US Patents Premium Feb 25, 2014 IP Watch: Roche, Life Tech, Pacific Biosciences, Promega, Others Win US Patents Premium Dec 31, 2013 IP Watch: Hologic, Roche, Qiagen, Samsung, Johns Hopkins, Others Win US Patents Premium Oct 17, 2013 IP Watch: Bio-Rad, Grifols Therapeutics, Samsung, Life Tech, Eiken, and Enzo Win US Patents Premium Sep 4, 2013 IP Watch: X-Bar Diagnostic Systems, Samsung, UPenn, Others Win US Patents Premium Jul 2, 2013 IP Roundup: Panasonic, Samsung, JSR, Illumina, Plexera, Agilent Premium Jun 25, 2013 IP Roundup: Samsung, Panasonic, U of Illinois, Affymetrix, Illumina, Pathwork Dx Premium May 1, 2013 IP Watch: Sony Micronics, PATH, Life Tech, IntegenX, Samsung, Others Win US Patents Premium Apr 18, 2013 IP Watch: Quanta Biosciences, FujiFilm, Hologic, Samsung, U of California, Others Win US Patents Premium Feb 28, 2013 IP Watch: Samsung, Becton Dickinson, Sequenom, Stanford, Trovagene, iCubate, Win US Patents Premium Jan 2, 2013 IP Watch: Quest, Takara Bio, Hologic, Fluidigm, Roche, LLNL, Bio-Rad, Others Win US Patents Premium Dec 18, 2012 IP Roundup: Illumina, Applied Precision, Samsung, NuGen Premium Oct 4, 2012 IP Watch: Genera Biosystems, Life Tech, USDHHS, Hologic, and Samsung Win US Patents Premium Sep 26, 2012 IP Watch: Hologic, PerkinElmer, Samsung, Becton Dickinson, and Intel Win US Patents Premium Sep 25, 2012 IP Roundup: Affymetrix, Scienion, Bio-Layer, Canon, Samsung, Cal Tech Premium Sep 11, 2012 IP Roundup: Columbia University, MIT, Plexera, Samsung Electronics Premium Aug 28, 2012 IP Roundup: California Institute of Technology, Eppendorf Array Technologies, Samsung Electronics Premium Jul 19, 2012 IP Watch: Samsung, BioMerieux, Bio-Rad, Abbott, Micronics, Argos, BD, and Gen-Probe Win US Patents Premium Jul 17, 2012 IP Roundup: Agilent Technologies, Quanterix, Samsung Electronics, Affymetrix Premium May 22, 2012 IP Watch: Gen-Probe, Qiagen, BD, PrimeraDx, Samsung, Hitachi, and Bioinnovations Win US Patents Premium Load More Breaking News Long COVID Clues Found in Acute SARS-CoV-2 Infection Blood Samples People in the News at Roche, Mammoth Biosciences, NeoGenomics, Molecular Assemblies, More New Products Posted to GenomeWeb: Thermo Fisher, Element Biosciences, Dante Genomics, More Tesis Biosciences to Develop miRNA Biomarkers for mTBI Diagnosis In Brief This Week: Danaher, Lucira Health, Novacyt, Molecular Devices The Scan Cell Atlas of Human Lung Development Gives View of Developing Airway Researchers have generated a cell atlas of human lung development, which they report in Cell. Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis. Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity. Study Links Genetic Risk for ADHD With Alzheimer's Disease A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.